Site-specific oral absorption of didanosine: in situ characterization and correlation with extent of absorption in vivo

[1]  M. Wientjes,et al.  Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[2]  F. Valentine,et al.  Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome—related complex , 1991, Clinical pharmacology and therapeutics.

[3]  S. Broder,et al.  Pharmacokinetics of 2',3' ‐dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications , 1991, Clinical pharmacology and therapeutics.

[4]  D. Fleisher,et al.  Fed-state effects on zidovudine absorption. , 1991, AIDS.

[5]  V. Stella,et al.  Preformulation solubility and kinetic studies of 2',3'-dideoxypurine nucleosides: potential anti-AIDS agents , 1988 .

[6]  D. A. Johnson,et al.  Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. , 1988, Journal of theoretical biology.

[7]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[8]  J. Boyer,et al.  Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier. , 1984, The Journal of biological chemistry.

[9]  G. Semenza,et al.  A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. , 1978, Biochimica et biophysica acta.